Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes

Class:IdLiteratureReference:9725240
_displayNameFunctional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
_timestamp2021-03-29 11:33:26
author[Person:9667885] Piva, Roberto
[Person:9701337] Pellegrino, Elisa
[Person:9725238] Mattioli, Michela
[Person:9725239] Agnelli, Luca
[Person:2032850] Lombardi, L
[Person:9710819] Boccalatte, Francesco
[Person:9725241] Costa, Giulia
[Person:9701324] Ruggeri, Bruce A
[Person:9632771] Cheng, Mangeng
[Person:9667884] Chiarle, Roberto
[Person:9710820] Palestro, Giorgio
[Person:2032860] Neri, A
[Person:9648424] Inghirami, Giorgio
created[InstanceEdit:9725242] Rothfels, Karen, 2021-03-29
journalJ Clin Invest
pages3171-82
pubMedIdentifier17111047
titleFunctional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
volume116
year2006
(literatureReference)[RegulationReference:9725634] Positive regulation by 'p-T,Y MAPK monomers and dimers [nucleoplasm]' Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
[RegulationReference:9725635] Positive regulation by 'NPM1(1-117)-p-7Y ALK(1058-1620) fusion dimer [nucleoplasm]' Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
[RegulationReference:9725638] Positive regulation by 'NPM1(1-117)-p-7Y ALK(1058-1620) fusion dimer [nucleoplasm]' Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
[RegulationReference:9725639] Positive regulation by 'p-Y705,S727-STAT3 dimer [nucleoplasm]' Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
[BlackBoxEvent:9725338] NPM1-ALK-dependent BCL2A1 gene expression [Homo sapiens]
[BlackBoxEvent:9725342] NPM1-ALK-dependent JUNB gene transcription [Homo sapiens]
[BlackBoxEvent:9725357] NPM1-ALK-dependent CEBPB gene expression [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes (9725240)
Follow Reactome